67. 多発性嚢胞腎 Polycystic kidney disease Clinical trials / Disease details

臨床試験数 : 221 / 薬物数 : 212 - (DrugBank : 55) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 151

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05373264 (ClinicalTrials.gov)	February 2023	28/4/2022	HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life	HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life	ADPKD	Drug: Hydrochlorothiazide 25 mg;Drug: Placebo	University Medical Center Groningen	NULL	Not yet recruiting	18 Years	80 Years	All	300	Phase 3	Belgium;France;Germany;Netherlands;Spain;United Kingdom;United States
2	EUCTR2017-003864-10-NL (EUCTR)	02/05/2018	08/03/2018	Medication for excessive urine production in patients treated with tolvaptan	Hydrochlorothiazideand metformin cross-over study for attenuating aquaretic side-effects in ADPKD pa ...	Autosomal dominant polycystic kidney disease;Therapeutic area: Diseases [C] - Symptoms and general p ...	Product Name: Hydrochlorothiazide Product Code: HCT Product Name: Metformin	University Medical Center Groningen	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2	Netherlands

First Previous1Next Last